▁ 10.375
8 3.541015625
% 4.04296875
▁of 2.98046875
▁the 1.86328125
▁residents 7.09765625
▁of 2.578125
▁progress 12.3125
ive 1.009765625
▁countries 4.53515625
▁have 2.763671875
▁chron 9.3125
ic 0.023162841796875
▁pain 4.53515625
, 2.15625
▁which 3.2890625
▁is 1.025390625
▁considered 5.3828125
▁to 0.8203125
▁be 0.1966552734375
▁an 3.052734375
▁extreme 5.4296875
▁issue 5.76953125
. 1.517578125
<0x0A> 1.517578125
There 4.078125
▁is 1.2470703125
▁currently 4.7578125
▁a 1.142578125
▁severe 5.015625
▁lack 3.14453125
▁of 0.040496826171875
▁information 2.943359375
▁about 1.36328125
▁the 1.927734375
▁effects 4.0234375
▁of 0.202880859375
▁op 4.7109375
i 3.23046875
ates 0.0273284912109375
. 2.75
▁They 4.640625
▁manage 9.1171875
▁pain 3.099609375
▁successfully 6.234375
, 1.171875
▁but 0.53564453125
▁the 2.529296875
▁past 9.7890625
▁few 1.75390625
▁dec 1.171875
ades 0.00011658668518066406
▁indicated 9.875
▁the 2.65625
▁growing 4.9609375
▁concern 4.0703125
▁regarding 3.208984375
▁op 3.10546875
iate 0.45361328125
▁ab 1.80078125
use 0.00994110107421875
▁in 3.150390625
▁forms 10.8359375
▁of 0.6298828125
▁over 4.2734375
d 0.4599609375
ose 0.148681640625
▁and 0.912109375
▁add 1.0966796875
iction 0.0248870849609375
. 0.2060546875
▁A 4.640625
▁more 5.58203125
▁manage 8.671875
able 0.0023174285888671875
▁and 2.29296875
▁sa 2.609375
fer 0.0001227855682373047
▁alternative 1.810546875
▁might 6.00390625
▁be 0.260498046875
▁medical 6.046875
▁mar 0.42431640625
iju 0.0022754669189453125
ana 0.0002548694610595703
. 1.0283203125
▁However 3.857421875
, 0.00829315185546875
▁the 1.76171875
▁legal 3.458984375
▁status 1.525390625
▁and 3.16796875
▁novel 9.828125
ty 0.61572265625
▁of 0.29296875
▁this 1.99609375
▁drug 2.318359375
▁do 5.65234375
▁not 0.1153564453125
▁allow 1.2236328125
▁finding 9.375
▁a 2.01171875
▁large 5.26171875
▁number 1.291015625
▁of 0.0072174072265625
▁studies 1.5517578125
▁on 1.638671875
▁its 1.3125
▁effect 2.03125
iveness 0.357421875
. 1.08203125
▁Specifically 8.3359375
, 0.126708984375
▁it 2.78515625
▁concerns 6.27734375
▁the 0.7099609375
▁emot 9.3203125
ional 0.0160064697265625
▁condition 5.7265625
▁of 0.76171875
▁patients 1.244140625
▁experien 5.9375
cing 6.0439109802246094e-05
▁chron 1.638671875
ic 0.0006508827209472656
▁pain 0.10650634765625
. 0.70703125
▁This 3.45703125
▁research 3.77734375
▁paper 3.712890625
▁a 1.763671875
ims 0.0002105236053466797
▁to 0.11181640625
▁analyze 2.763671875
▁levels 10.7265625
▁of 0.046173095703125
▁de 2.154296875
pression 0.0667724609375
▁and 0.8330078125
▁anx 0.490234375
iety 0.0005602836608886719
▁among 1.8291015625
▁people 3.181640625
▁receiving 4.078125
▁ther 5.078125
apy 0.06427001953125
▁by 5.140625
▁comparing 5.41796875
▁the 1.4228515625
▁effects 2.375
▁of 0.079833984375
▁ph 6.125
arma 0.8134765625
ce 0.0014362335205078125
ut 0.0001055002212524414
ical 0.009063720703125
▁op 1.26953125
io 1.646484375
ids 0.309326171875
▁and 1.1298828125
▁MM 7.46875
. 7.48828125
<0x0A> 0.7353515625
The 1.7353515625
▁study 3.00390625
▁was 1.9150390625
▁conducted 0.818359375
▁in 1.5625
▁the 1.5478515625
▁form 2.82421875
▁of 0.006710052490234375
▁collection 9.8203125
▁and 1.8505859375
▁analysis 0.6572265625
▁of 0.052734375
▁statistical 4.51953125
▁data 0.109619140625
. 0.98974609375
▁Part 5.46484375
icip 0.09832763671875
ants 0.0408935546875
▁were 0.72021484375
▁rec 2.91015625
ru 0.001384735107421875
ited 3.993511199951172e-05
▁for 3.626953125
▁six 7.515625
▁months 0.68017578125
▁at 3.759765625
▁two 2.890625
▁major 5.67578125
▁pain 3.693359375
▁relief 6.45703125
▁cent 1.4052734375
ers 0.0298614501953125
▁in 0.6728515625
▁Israel 4.03125
. 0.39501953125
▁The 1.267578125
▁research 2.751953125
ers 1.154296875
▁used 2.4140625
▁The 8.0
▁De 3.73046875
pression 0.01082611083984375
▁Module 10.2890625
▁of 1.037109375
▁the 0.29052734375
▁Pat 2.201171875
ient 0.005035400390625
▁Health 0.07098388671875
▁Question 0.0158843994140625
naire 0.0195159912109375
▁and 3.201171875
▁the 0.56640625
▁General 1.3828125
ized 0.69140625
▁An 0.01450347900390625
x 0.00018095970153808594
iety 0.0016117095947265625
▁Dis 0.39306640625
order 0.03546142578125
▁Sc 1.400390625
ale 0.0687255859375
▁to 1.791015625
▁interview 7.53515625
▁participants 1.9013671875
, 3.564453125
▁evaluate 5.98828125
▁their 0.75732421875
▁answers 6.23046875
, 0.8447265625
▁and 0.138427734375
▁conduct 4.60546875
▁the 2.37890625
▁study 2.423828125
. 0.1947021484375
▁To 5.23828125
▁specifically 9.7578125
▁evaluate 2.517578125
▁and 4.14453125
▁compare 0.9951171875
▁the 0.318115234375
▁prob 11.796875
abilities 0.3046875
▁of 0.1846923828125
▁de 1.34765625
pression 0.041168212890625
▁or 4.05859375
▁anx 0.037872314453125
iety 0.0002636909484863281
▁among 1.9677734375
▁the 1.875
▁diverse 9.2421875
▁groups 1.58203125
, 1.521484375
▁the 1.0556640625
▁study 2.935546875
▁used 1.7041015625
▁multiple 4.609375
▁log 2.90625
istic 0.04229736328125
▁regression 0.101318359375
▁analysis 0.70556640625
▁and 2.6328125
▁chose 9.1015625
▁medical 7.8671875
▁mar 0.732421875
iju 0.0014352798461914062
ana 6.103515625e-05
▁as 0.67138671875
▁the 0.94287109375
▁control 2.310546875
▁group 0.55126953125
. 0.27783203125
<0x0A> 0.6494140625
This 3.28125
▁type 5.38671875
▁of 0.005588531494140625
▁study 1.4384765625
▁is 1.5185546875
▁the 3.33203125
▁most 1.8271484375
▁reve 9.46875
aling 0.0006756782531738281
▁and 1.037109375
▁inclus 6.33984375
ive 0.0024433135986328125
, 2.2890625
▁as 1.916015625
▁it 0.40478515625
▁contains 4.9375
▁direct 6.734375
▁responses 4.828125
▁from 0.82177734375
▁a 3.8203125
▁large 0.935546875
▁number 0.427734375
▁of 0.0037593841552734375
▁participants 1.3095703125
. 0.677734375
▁All 4.640625
▁tools 9.171875
▁in 4.37109375
▁the 0.7255859375
▁form 3.609375
▁of 0.041748046875
▁question 1.7568359375
na 0.046600341796875
ires 0.00011086463928222656
▁and 2.17578125
▁scales 2.818359375
▁have 3.6875
▁already 4.75390625
▁been 0.161376953125
▁used 1.9140625
▁and 2.1640625
▁proved 4.46875
▁their 1.9755859375
▁effic 3.748046875
acy 0.0003097057342529297
▁for 3.58203125
▁collect 4.71875
ing 0.0190582275390625
▁analyt 8.4453125
ical 0.248046875
▁data 0.288818359375
. 0.466552734375
▁It 3.705078125
▁helps 5.0078125
▁to 1.0791015625
▁system 7.5390625
at 1.390625
ize 0.006023406982421875
▁and 1.5703125
▁class 4.13671875
ify 0.0028972625732421875
▁distinct 9.125
▁kinds 5.90234375
▁of 0.0225830078125
▁information 3.0859375
▁for 3.73828125
▁subsequent 4.4140625
▁un 8.1953125
comp 5.47265625
licated 0.061004638671875
▁services 11.6640625
. 0.6787109375
▁Thus 4.21484375
, 0.0197601318359375
▁research 4.39453125
ers 0.52880859375
▁can 1.3818359375
▁compare 3.921875
▁the 1.083984375
▁effects 2.55859375
▁of 0.1219482421875
▁medic 4.36328125
ations 0.92041015625
▁on 1.71484375
▁patients 2.166015625
▁of 4.30859375
▁diverse 3.73828125
▁age 2.916015625
▁groups 0.6474609375
, 0.9228515625
▁background 4.9453125
s 0.1947021484375
, 0.06256103515625
▁physical 5.4296875
▁conditions 1.294921875
, 0.07183837890625
▁emot 5.4140625
ional 0.073974609375
▁states 1.3466796875
, 0.08685302734375
▁and 0.41650390625
▁so 3.0078125
▁on 0.27001953125
. 0.09710693359375
<0x0A> 0.6591796875
The 1.3408203125
▁analysis 4.44921875
▁of 0.6494140625
▁any 8.2265625
▁human 5.9453125
▁reaction 4.82421875
▁has 4.4375
▁a 1.7919921875
▁high 4.4296875
▁potential 3.244140625
▁of 1.6982421875
▁subject 7.02734375
iveness 3.8828125
▁and 1.3193359375
▁bias 2.20703125
. 0.410888671875
<0x0A> 5.65625
The 1.6494140625
▁study 2.373046875
▁included 3.921875
▁ 1.158203125
8 3.064453125
9 2.74609375
0 2.771484375
▁participants 1.146484375
, 1.2880859375
▁of 1.939453125
▁which 0.332275390625
▁ 0.15185546875
4 1.53515625
7 2.51953125
4 2.681640625
▁were 0.8134765625
▁treated 4.2421875
▁sole 6.515625
ly 8.821487426757812e-05
▁with 0.302490234375
▁op 0.810546875
io 0.4306640625
ids 0.232421875
, 1.0927734375
▁ 0.79833984375
3 1.0830078125
2 1.95703125
9 2.583984375
▁were 1.2294921875
▁treated 0.57568359375
▁with 0.1534423828125
▁MM 1.5673828125
, 0.198974609375
▁and 0.14697265625
▁ 0.1796875
7 3.771484375
7 2.490234375
▁were 0.734375
▁treated 0.93408203125
▁with 0.143798828125
▁place 4.94921875
bo 0.36279296875
. 0.2147216796875
<0x0A> 1.6591796875
The 0.98046875
▁study 2.048828125
▁looked 6.90625
▁at 0.44189453125
▁the 0.96923828125
▁inter 7.08984375
dep 4.953125
end 0.0011091232299804688
ence 0.01279449462890625
▁of 0.413818359375
▁various 4.0234375
▁factors 1.63671875
▁that 2.119140625
▁affected 3.82421875
▁the 0.478271484375
▁physical 7.22265625
▁and 0.64453125
▁emot 0.84521484375
ional 0.0003428459167480469
▁condition 0.9765625
▁of 0.08416748046875
▁patients 0.8046875
. 0.74560546875
<0x0A> 0.720703125
The 0.880859375
▁question 5.5234375
na 0.79052734375
ires 8.976459503173828e-05
▁used 1.94140625
▁different 8.2265625
▁variable 9.7421875
▁measures 4.48828125
▁to 1.5771484375
▁collect 2.328125
▁information 2.060546875
. 1.7197265625
▁For 3.74609375
▁example 0.342529296875
, 0.0199432373046875
▁it 4.21484375
▁included 2.3828125
▁compreh 8.9921875
ensive 0.024566650390625
▁so 7.265625
cio 0.0179595947265625
- 0.74560546875
dem 0.15869140625
ographic 0.0357666015625
▁data 1.134765625
: 5.6796875
▁gender 1.546875
, 0.07806396484375
▁age 0.2218017578125
, 0.10565185546875
▁country 4.26953125
, 1.4453125
▁type 4.3125
▁of 0.050262451171875
▁residence 3.5078125
▁( 3.677734375
urban 1.8681640625
/ 3.087890625
r 0.064697265625
ural 0.0004239082336425781
), 0.2413330078125
▁years 5.91015625
▁of 0.1517333984375
▁education 0.76171875
, 0.1397705078125
▁and 1.8525390625
▁employ 3.681640625
ment 0.0038909912109375
▁status 0.406494140625
. 0.172119140625
▁Pat 5.328125
ients 0.1571044921875
▁were 1.08203125
▁also 0.78955078125
▁asked 0.6015625
▁about 0.97216796875
▁their 0.58154296875
▁medical 2.529296875
▁history 0.352783203125
▁over 9.1953125
▁the 0.1754150390625
▁years 3.533203125
▁and 1.9833984375
▁the 1.8779296875
▁current 3.443359375
▁presence 5.65234375
▁of 0.051666259765625
▁any 2.44921875
▁severe 5.33984375
▁dise 1.7470703125
ases 2.9921531677246094e-05
▁such 4.17578125
▁as 0.002773284912109375
▁heart 2.392578125
▁failure 2.07421875
, 0.207763671875
▁di 1.89453125
ab 0.0017337799072265625
etes 0.00434112548828125
, 0.1192626953125
▁ar 4.09765625
th 0.1361083984375
rit 0.030670166015625
is 0.0084991455078125
, 0.05169677734375
▁and 1.59765625
▁so 0.70068359375
▁on 0.032135009765625
. 0.023223876953125
▁The 2.435546875
▁third 7.1640625
▁measure 4.03515625
▁of 2.0625
▁the 1.076171875
▁question 2.37109375
naire 0.2352294921875
▁was 0.7890625
▁indicated 9.515625
▁by 0.62744140625
▁information 6.08984375
▁on 1.3984375
▁any 4.71875
▁twelve 13.65625
- 1.3486328125
month 0.416015625
▁and 5.8828125
▁lifetime 3.365234375
▁drug 4.31640625
▁and 3.75390625
▁alco 0.05120849609375
hol 5.888938903808594e-05
▁consumption 2.533203125
. 0.440673828125
▁In 3.732421875
▁addition 0.63720703125
, 0.126708984375
▁the 1.2001953125
▁record 7.8046875
▁included 1.8818359375
▁a 2.759765625
▁pain 6.70703125
▁measurement 4.36328125
▁scale 1.1064453125
▁from 3.404296875
▁ 0.398681640625
0 0.362060546875
▁to 0.39892578125
▁ 0.006931304931640625
1 0.0545654296875
0 0.048980712890625
▁to 4.53125
▁evaluate 1.7578125
▁dis 5.859375
com 0.107666015625
fort 0.00048542022705078125
▁feelings 7.44140625
▁during 3.296875
▁the 0.9384765625
▁last 1.861328125
▁month 1.625
. 0.263916015625
<0x0A> 0.7890625
There 4.578125
▁were 0.9140625
▁many 4.4140625
▁dis 5.8359375
orders 1.931640625
▁among 2.814453125
▁patients 1.3994140625
▁in 3.947265625
▁the 0.6787109375
▁op 5.87890625
iate 1.4677734375
, 5.90234375
▁medical 3.529296875
▁mar 0.0609130859375
iju 0.003559112548828125
ana 5.626678466796875e-05
, 0.07049560546875
▁and 0.07269287109375
▁mixed 9.59375
▁OP 10.2109375
MM 5.98828125
▁groups 0.4580078125
. 0.3349609375
<0x0A> 2.0
The 1.1396484375
▁high 6.69921875
▁response 5.4375
▁rate 0.174072265625
▁is 4.390625
▁due 3.8359375
▁to 0.01499176025390625
▁the 0.349609375
▁weak 10.75
▁focus 7.640625
▁of 0.72705078125
▁respond 7.88671875
ents 0.1884765625
▁who 3.978515625
▁have 3.611328125
▁overcome 7.6875
▁severe 2.755859375
▁pain 1.126953125
▁sens 8.515625
ations 1.34765625
▁and 1.431640625
▁de 4.90625
pression 0.17041015625
. 0.8291015625
